Accueil > Actualité
Actualite financiere : Actualite bourse

Novacyt: hit by news from UK

( - Novacyt shares are down 3% after the latest news regarding the marketing of its Covid-19 tests in the UK following the implementation of the 2021 medical device regulations passed by the UK Health Security Agency (CTDA).

Since 1 November, the company has only been selling the PROmate COVID-19 test in the UK until the CTDA completes its review of the nine additional products submitted, which could only be sold until 31 October.

If no further products are added to the CTDA register, the impact on annual revenues for 2021 will be around 3 million pounds, the French clinical diagnostics specialist warned.

Copyright (c) 2021 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.